Scott Gavura
Scott Gavura publishes mostly in Economics and Econometrics, Oncology and Pulmonary and Respiratory Medicine, on topics such as Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life and Pancreatic and Hepatic Oncology Research.
- World rank
- #891,976 of 7,710,434 ranked researchers
- Rank in Canada
- #30,638 of 183,316
- Works
- 68
- Citations
- 933
- Citations per work
- 13.7
What does Scott Gavura research?
Scott Gavura's work is mostly in Medicine (37%), Economics, Econometrics and Finance (31%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2536.7%
- Medicine2536.7%
- Social Sciences2131.0%
- Everything else1928.2%
- Life Sciences34.1%
- 1Economics and Econometrics31% of their works
- 2Oncology24% of their works
- 3Pulmonary and Respiratory Medicine5% of their works
- 4Cardiology and Cardiovascular Medicine4% of their works
- 5Immunology4% of their works
- 6Surgery4% of their works
Research topics
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Pancreatic and Hepatic Oncology Research
- Pharmaceutical Economics and Policy
- Biosimilars and Bioanalytical Methods
- Chemotherapy-induced cardiotoxicity and mitigation
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Which keywords describe Scott Gavura's research?
The keywords of their largest research topics: Cost of Care, Financial Toxicity, Chemotherapy, Cost-effectiveness Analysis, Quality of Life, Immunotherapy, Trastuzumab and Pancreatic Cancer.
- Doxorubicin
- CAR T Cells
- Anthracyclines
- Biosimilars
- Drug Development Costs
- Pancreatic Cancer
- Immunotherapy
- Cost-effectiveness Analysis
- Financial Toxicity
- Cost of Care
- Chemotherapy
- Quality of Life
- Trastuzumab
- Surgical Complications
- Generic Drugs
- Immunogenicity
- Breast Cancer
- Chimeric Antigen Receptor
- HER2
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cost of Care291 topic
- Financial Toxicity291 topic
- Chemotherapy233 topics
- Cost-effectiveness Analysis221 topic
- Quality of Life221 topic
- Immunotherapy172 topics
- Trastuzumab122 topics
- Pancreatic Cancer111 topic
- Surgical Complications111 topic
- Drug Development Costs101 topic
- Generic Drugs101 topic
- Biosimilars71 topic
- Immunogenicity71 topic
- Anthracyclines61 topic
- Breast Cancer61 topic
- CAR T Cells61 topic
- Chimeric Antigen Receptor61 topic
- Doxorubicin61 topic
- HER261 topic
Where does Scott Gavura work?
Scott Gavura's main affiliation in the publication record is Cancer Care Ontario, Canada.
How many publications and citations does Scott Gavura have?
OpenAlex counts 68 works and 933 citations for Scott Gavura, an h-index of 15, ranking #891,976 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Scott Gavura. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.